Impact of GDT in Robot-assisted Laparoscopic Urological Surgery for Low to Moderate Risk Patients



Status:Withdrawn
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:4/17/2018
Start Date:December 2017
End Date:April 2018

Use our guide to learn which trials are right for you!

Impact of Goal Directed Fluid Therapy in Robot-assisted Laparoscopic Urological Surgery for Low to Moderate Risk Patients

Robot assisted urological procedures are often long surgical cases that can potentially
result in complicated postoperative hospital course. The amount of intravenous (IV) fluids
administered to patients during these operations fluctuates based on the length of the case,
surgical blood loss, hemodynamic monitors, and the discretion of the anesthesiologist. The
goal of intraoperative fluid therapy is to maintain optimal tissue perfusion without causing
fluid overload. We plan to use a goal directed fluid therapy protocol to optimize fluid
status and analyze post-operative outcomes.


Inclusion Criteria:

- Patients undergoing robot-assisted laparoscopic urological procedures in which the
patient would have an arterial catheter placed as part of their routine inoperative
anesthetic management

Exclusion Criteria:

- Age less than 18;

- current pregnancy;

- history of congestive heart failure, arrhythmias, coagulopathy, cerebral vascular
disease , COPD, significant liver or renal impairment, required FloTrac per treating
anesthesiologist;

- patient refusal to consent
We found this trial at
1
site
Loma Linda University
Loma Linda, California 92354
(909) 558-4000
Loma Linda University Loma Linda University (LLU) is a Seventh-day Adventist educational health-sciences institution with...
?
mi
from
Loma Linda, CA
Click here to add this to my saved trials